Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Abola M.T.B., Golledge J., Miyata T., Rha S.-W., Yan B.P., Dy T.C., Ganzon M.S.V., Handa P.K., Harris S., Zhisheng J., Pinjala R., Robless P.A., Yokoi H., Alajar E.B., Santos A.A.B.-D., Llanes E.J.B., Obrado-Nabablit G.M., Pestaño N.S., Punzalan F.E., Tumanan-Mendoza B., Janus E., Sy R.G., Yamashita S., Collado F.R., Garcia F.A., Dakota I., Higashi Y., Suhartono R., Steering Committee, Consensus Panel, Technical Working Group
36830907200;7005096118;57077756000;8569030400;7201858670;6506812508;6504105147;12759570700;55325116600;57204466187;57220192866;6701561745;7201964038;57200121236;57218885398;55977373600;57218405104;57193787524;34880720300;16305669400;57203254342;6603388395;57218885400;57218885345;57201842866;55796663700;7202858910;57218884615;
Asia-Pacific consensus statement on the management of peripheral artery disease: A report from the Asian Pacific society of atherosclerosis and vascular disease Asia-Pacific peripheral artery disease consensus statement project committee
2020
Journal of Atherosclerosis and Thrombosis
27
8
809
907
Department of Clinical Research, Philippine Heart Center, University of the Philippines College of Medicine, Metro Manila, Philippines; Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Australia; Department of Vascular and Endovascular Surgery, The Townsville Hospital, Townsville, QLD, Australia; Vascular Center, Sanno Hospital and Sanno Medical Center, Tokyo, Japan; Dept of Cardiology, Internal Medicine, College of Medicine, Korea University, South Korea; Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea; Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong; The Heart Institute, Chinese General Hospital and Medical Center, Manila, Philippines; Dr. HBCalleja Heart and Vascular Institute, St. Luke’s Medical Center, Quezon City, Philippines; Department of General Medicine, Tan Tock Seng Hospital, Singapore; Neurovascular and Neurosonology Division, Neurology Department, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; University of South China, Hengyang, Hunan, China; Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana state, India; Robless Vascular Clinic, Singapore; Cardiovascular Center, Fukuoka Sanno Hospital, International University of Health and Welfare, Fukuoka, Japan; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, University of the Philippines College of Medicine, Manila, Philippines; Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, Manila, Philippines; Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines Philippine General Hospital, Manila, Philippines; Department of Clinical Epidemiology, University of the Philippines College of Medicine, Manila, Philippines
Abola, M.T.B., Department of Clinical Research, Philippine Heart Center, University of the Philippines College of Medicine, Metro Manila, Philippines; Golledge, J., Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Australia, Department of Vascular and Endovascular Surgery, The Townsville Hospital, Townsville, QLD, Australia; Miyata, T., Vascular Center, Sanno Hospital and Sanno Medical Center, Tokyo, Japan; Rha, S.-W., Dept of Cardiology, Internal Medicine, College of Medicine, Korea University, South Korea, Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea; Yan, B.P., Division of Cardiology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong; Dy, T.C., The Heart Institute, Chinese General Hospital and Medical Center, Manila, Philippines; Ganzon, M.S.V., Dr. HBCalleja Heart and Vascular Institute, St. Luke’s Medical Center, Quezon City, Philippines; Handa, P.K., Department of General Medicine, Tan Tock Seng Hospital, Singapore; Harris, S., Neurovascular and Neurosonology Division, Neurology Department, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; Zhisheng, J., University of South China, Hengyang, Hunan, China; Pinjala, R., Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana state, India; Robless, P.A., Robless Vascular Clinic, Singapore; Yokoi, H., Cardiovascular Center, Fukuoka Sanno Hospital, International University of Health and Welfare, Fukuoka, Japan; Alajar, E.B., Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, University of the Philippines College of Medicine, Manila, Philippines; Santos, A.A.B.-D., Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, Manila, Philippines; Llanes, E.J.B., Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines Philippine General Hospital, Manila, Philippines; Obrado-Nabablit, G.M., Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, Manila, Philippines; Pestaño, N.S., Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital, Manila, Philippines; Punzalan, F.E., Division of Cardiology, Department of Medicine, College of Medicine, University of the Philippines Philippine General Hospital, Manila, Philippines; Tumanan-Mendoza, B., Department of Clinical Epidemiology, University of the Philippines College of Medicine, Manila, Philippines; Janus, E.; Sy, R.G.; Yamashita, S.; Collado, F.R.; Garcia, F.A.; Dakota, I.; Higashi, Y.; Suhartono, R.; Steering Committee; Consensus Panel; Technical Working Group
Background: Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic modalities, and even patient treatment response. The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) thus coordinated the development of an Asia-Pacific Consensus Statement (APCS) on the Management of PAD. Objectives: The APSAVD aimed to accomplish the following: 1) determine the applicability of the 2016 AHA/ ACC guidelines on the Management of Patients with Lower Extremity Peripheral Artery Disease to the Asia- Pacific region; 2) review Asia-Pacific literature; and 3) increase the awareness of PAD. Methodology: A Steering Committee was organized to oversee development of the APCS, appoint a Technical Working Group (TWG) and Consensus Panel (CP). The TWG appraised the relevance of the 2016 AHA/ACC PAD Guideline and proposed recommendations which were reviewed by the CP using a modified Delphi technique. Results: A total of 91 recommendations were generated covering history and physical examination, diagnosis, and treatment of PAD-3 new recommendations, 31 adaptations and 57 adopted statements. This Asia-Pacific Consensus Statement on the Management of PAD constitutes the first for the Asia-Pacific Region. It is intended for use by health practitioners involved in preventing, diagnosing and treating patients with PAD and ultimately the patients and their families themselves. © 2020 Japan Atherosclerosis Society.
Acute limb ischemia; Critical limb ischemia; Intermittent claudication; Peripheral artery disease
Japan Atherosclerosis Society
13403478
32624554
Article
Q1